osa syndrome and allergic respiratory diseases upper airway diseases a. kaditis, md
DESCRIPTION
OSA SYNDROME AND ALLERGIC RESPIRATORY DISEASES Upper Airway Diseases A. Kaditis, MD. Pediatric Pulmonology Unit, Sleep Disorders Laboratory First Department of Pediatrics University of Athens School of Medicine and Aghia Sophia Children’s Hospital Athens, Greece. - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: OSA SYNDROME AND ALLERGIC RESPIRATORY DISEASES Upper Airway Diseases A. Kaditis, MD](https://reader036.vdocuments.us/reader036/viewer/2022062309/56813b7d550346895da49620/html5/thumbnails/1.jpg)
OSA SYNDROME AND ALLERGIC RESPIRATORY DISEASES
Upper Airway Diseases
A. Kaditis, MD
Pediatric Pulmonology Unit, Sleep Disorders Laboratory
First Department of Pediatrics
University of Athens School of Medicine
and Aghia Sophia Children’s Hospital
Athens, Greece
![Page 2: OSA SYNDROME AND ALLERGIC RESPIRATORY DISEASES Upper Airway Diseases A. Kaditis, MD](https://reader036.vdocuments.us/reader036/viewer/2022062309/56813b7d550346895da49620/html5/thumbnails/2.jpg)
Obstructive Sleep-Disordered Breathing (SDB)
Spectrum of abnormal respiratory patterns during sleep characterized by snoring and increased respiratory effort
Primary snoring Upper airway resistance syndrome Obstructive hypoventilation Obstructive sleep apnea (OSA)
![Page 3: OSA SYNDROME AND ALLERGIC RESPIRATORY DISEASES Upper Airway Diseases A. Kaditis, MD](https://reader036.vdocuments.us/reader036/viewer/2022062309/56813b7d550346895da49620/html5/thumbnails/3.jpg)
Multiple Disorders affecting components of the Upper Airway (e.g. tonsils, facial structures, dilator muscles)
Upper Airway Dysfunction over time may lead to overt morbidity (e.g. hypertension, enuresis, EDS)
Genes, environment
Genes, environment
Upper Airway Resistance
OSA: Syndrome of Upper Airway Dysfunction
![Page 4: OSA SYNDROME AND ALLERGIC RESPIRATORY DISEASES Upper Airway Diseases A. Kaditis, MD](https://reader036.vdocuments.us/reader036/viewer/2022062309/56813b7d550346895da49620/html5/thumbnails/4.jpg)
Apnea Hypopnea
![Page 5: OSA SYNDROME AND ALLERGIC RESPIRATORY DISEASES Upper Airway Diseases A. Kaditis, MD](https://reader036.vdocuments.us/reader036/viewer/2022062309/56813b7d550346895da49620/html5/thumbnails/5.jpg)
Step 1: Recognize the child at risk for obstructive SDB
Step 2: Identify SDB-related morbidity or conditions co-existing with SDB (probably common pathogenesis)
Step 3: Recognize factors predicting persistence of SDB
Step 4: Assess severity of SDB objectively (if equipment available)
Step 5: Determine indications for treatment
Step 6: Stepwise treatment approach for SDB
Step 7: Follow-up, diagnosis and management of persistent SDB
![Page 6: OSA SYNDROME AND ALLERGIC RESPIRATORY DISEASES Upper Airway Diseases A. Kaditis, MD](https://reader036.vdocuments.us/reader036/viewer/2022062309/56813b7d550346895da49620/html5/thumbnails/6.jpg)
Step 1: Recognize the child at risk for obstructive SDB
Assess by history + exam
Symptoms of nocturnal airway obstruction1. Snoring2. Reported apneas during sleep3. Difficulty breathing during sleep4. Restless sleep5. Frequent arousals
Abnormalities predisposing to upper airway obstruction 1. Adenotonsillar hypertrophy/allergic rhinitis 2. Obesity 3. Craniofacial abnormalities 4. Neuromuscular disorders
History increasing the risk for SDB 1. Premature birth2. Family history of SDB
![Page 7: OSA SYNDROME AND ALLERGIC RESPIRATORY DISEASES Upper Airway Diseases A. Kaditis, MD](https://reader036.vdocuments.us/reader036/viewer/2022062309/56813b7d550346895da49620/html5/thumbnails/7.jpg)
Upper Airway Dysfunction and Adenotonsillar Hypertrophy
![Page 8: OSA SYNDROME AND ALLERGIC RESPIRATORY DISEASES Upper Airway Diseases A. Kaditis, MD](https://reader036.vdocuments.us/reader036/viewer/2022062309/56813b7d550346895da49620/html5/thumbnails/8.jpg)
Villa et al. Randomized controlled study of an oral jaw-positioning device for treatment of OSA in children with malocclusion. AJRCCM 2002;165:123-7
![Page 9: OSA SYNDROME AND ALLERGIC RESPIRATORY DISEASES Upper Airway Diseases A. Kaditis, MD](https://reader036.vdocuments.us/reader036/viewer/2022062309/56813b7d550346895da49620/html5/thumbnails/9.jpg)
Step 2: Identify SDB-related morbidity or conditions co-existing with SDB (probably common pathogenesis)
Morbidity Cardiovascular system Central nervous system Enuresis, inadequate
somatic growth
Conditions co-existing with SDB
Metabolic syndrome Recurrent otitis media,
serous otitis Recurrent wheezing
![Page 10: OSA SYNDROME AND ALLERGIC RESPIRATORY DISEASES Upper Airway Diseases A. Kaditis, MD](https://reader036.vdocuments.us/reader036/viewer/2022062309/56813b7d550346895da49620/html5/thumbnails/10.jpg)
Amin et al. Activity-adjusted 24-hour ambulatory BP and cardiac remodeling in children with SDB.
Hypertension 2008;51:84-91
![Page 11: OSA SYNDROME AND ALLERGIC RESPIRATORY DISEASES Upper Airway Diseases A. Kaditis, MD](https://reader036.vdocuments.us/reader036/viewer/2022062309/56813b7d550346895da49620/html5/thumbnails/11.jpg)
Obstructive SDB in Childhood and CNS Morbidity
Hyperactivity Inattention Excessive daytime sleepiness Learning problems
Evidence from population-based studies
![Page 12: OSA SYNDROME AND ALLERGIC RESPIRATORY DISEASES Upper Airway Diseases A. Kaditis, MD](https://reader036.vdocuments.us/reader036/viewer/2022062309/56813b7d550346895da49620/html5/thumbnails/12.jpg)
Kaditis et al. Enuresis and Snoring in Healthy Children. Urology 2006; 68:406-9
Variables Children with
enuresis
n = 43
Children without
enuresis
n = 1778
Adjusted odds ratio
(95% CI)Age≤ 9 y.o.> 9 y.o.
32 (74.4 %)11 (25.6 %)
904 (50.8 %)874 (49.2 %)
2.87 (1.43-5.76)baseline
GenderMaleFemale
34 (79.1 %)9 (20.9 %)
891 (50.1 %)887 (49.9 %)
3.73 (1.77-7.86)baseline
Habitual snoring†
YesNo
10 (23.3 %)33 (76.7 %)
125 (7 %)1653 (93 %)
3.54 (1.68-7.44)baseline
![Page 13: OSA SYNDROME AND ALLERGIC RESPIRATORY DISEASES Upper Airway Diseases A. Kaditis, MD](https://reader036.vdocuments.us/reader036/viewer/2022062309/56813b7d550346895da49620/html5/thumbnails/13.jpg)
Risk factors adjusted for race, obesity
Occasional wheeze
Persistent wheeze
Cough
History of asthma
AHI>10 OR (95% CI) p
3.29(1.24-8.94)
<0.05
7.45 (2.03-27.39)
<0.05
8.83(2.29-34.05)
<0.05
3.83(1.39-10.55)
<0.05
Redline et al. Risk Factors for SDB in Children. AJRCCM 199;159:1527
![Page 14: OSA SYNDROME AND ALLERGIC RESPIRATORY DISEASES Upper Airway Diseases A. Kaditis, MD](https://reader036.vdocuments.us/reader036/viewer/2022062309/56813b7d550346895da49620/html5/thumbnails/14.jpg)
Step 3: Recognize factors predicting persistence of SDB in the long term
Male gender Obesity Increasing body mass index
percentile
![Page 15: OSA SYNDROME AND ALLERGIC RESPIRATORY DISEASES Upper Airway Diseases A. Kaditis, MD](https://reader036.vdocuments.us/reader036/viewer/2022062309/56813b7d550346895da49620/html5/thumbnails/15.jpg)
Goodwin et al. Incidence and Remission of SDB and Related Symptoms in 6- to 17-y.o children.
J Pediatr 2010;157:57-61
6-11 y.o. Over 5 years 10-18 y.o.
Snore 15%
-70.8% remission
+10% new cases
9.7%
AHI ≥ 1 23.9%
-60% remission
+4.1% new cases
15.3%
![Page 16: OSA SYNDROME AND ALLERGIC RESPIRATORY DISEASES Upper Airway Diseases A. Kaditis, MD](https://reader036.vdocuments.us/reader036/viewer/2022062309/56813b7d550346895da49620/html5/thumbnails/16.jpg)
Goodwin et al. Incidence and Remission of SDB and Related Symptoms in 6- to 17-y.o children.
J Pediatr 2010;157:57-61
![Page 17: OSA SYNDROME AND ALLERGIC RESPIRATORY DISEASES Upper Airway Diseases A. Kaditis, MD](https://reader036.vdocuments.us/reader036/viewer/2022062309/56813b7d550346895da49620/html5/thumbnails/17.jpg)
Step 4: Assess severity of SDB objectively (if equipment available)
Nocturnal polysomnography Nocturnal polygraphy Nocturnal oximetry
![Page 18: OSA SYNDROME AND ALLERGIC RESPIRATORY DISEASES Upper Airway Diseases A. Kaditis, MD](https://reader036.vdocuments.us/reader036/viewer/2022062309/56813b7d550346895da49620/html5/thumbnails/18.jpg)
Step 5: Determine indications for treatment
Clinically important upper airway obstruction even during wakefulness
AHI>5 episodes/h (or positive screening method) irrespective of morbidity
AHI 1-5 and morbidity or treatable co-existing condition
AHI 1-5 and craniofacial abnormalities or neuromuscular disorders
AHI 1-5 and risk for long-term SDB persistence
![Page 19: OSA SYNDROME AND ALLERGIC RESPIRATORY DISEASES Upper Airway Diseases A. Kaditis, MD](https://reader036.vdocuments.us/reader036/viewer/2022062309/56813b7d550346895da49620/html5/thumbnails/19.jpg)
Step 6: Stepwise treatment approach for SDB
Wt control for obesity Antiinflammatory medications for mild
SDB prior to AT AT for adenotonsillar hypertrophy Orthodontic devices for mandibular
malpositioning, narrow maxilla nCPAP for i) residual SDB after AT or
orthodontic devices; ii) SDB related to obesity, craniofacial abnormalities; iii) neuromuscular disorders unresponsive to other measures
Craniofacial surgery if SDB not responsive to orthodontic devices, nCPAP
Tracheostomy if all other measures fail or while waiting for craniofacial surgery
![Page 20: OSA SYNDROME AND ALLERGIC RESPIRATORY DISEASES Upper Airway Diseases A. Kaditis, MD](https://reader036.vdocuments.us/reader036/viewer/2022062309/56813b7d550346895da49620/html5/thumbnails/20.jpg)
Berlucchi et al. The Role of Mometasone Nasal Spray in the Treatment of Adenoidal Hypertrophy.
Pediatrics 2007;119:e1392-1397
Mometasone 100 mcg/d (40 days)
vs. Placebo (40 days)
![Page 21: OSA SYNDROME AND ALLERGIC RESPIRATORY DISEASES Upper Airway Diseases A. Kaditis, MD](https://reader036.vdocuments.us/reader036/viewer/2022062309/56813b7d550346895da49620/html5/thumbnails/21.jpg)
Villa et al. Randomized controlled study of an oral jaw-positioning device for treatment of OSA in children with malocclusion. AJRCCM 2002;165:123-7
![Page 22: OSA SYNDROME AND ALLERGIC RESPIRATORY DISEASES Upper Airway Diseases A. Kaditis, MD](https://reader036.vdocuments.us/reader036/viewer/2022062309/56813b7d550346895da49620/html5/thumbnails/22.jpg)
Villa et al. Randomized controlled study of an oral jaw-positioning device for treatment of OSA in children with malocclusion. AJRCCM 2002;165:123-7
Before After
![Page 23: OSA SYNDROME AND ALLERGIC RESPIRATORY DISEASES Upper Airway Diseases A. Kaditis, MD](https://reader036.vdocuments.us/reader036/viewer/2022062309/56813b7d550346895da49620/html5/thumbnails/23.jpg)
Step 7: Follow-up, diagnosis and management of persistent SDB
Follow up after each therapeutic intervention and if no response move to the next intervention
Consider objective testing for selected children for selected children:
-High AHI pre-treatment
-post AT in children with obesity, craniofacial abnormalities, neuromuscular disorders
-post orthodontic treatment
-post nCPAP
-prior to craniofacial surgery or tracheostomy
![Page 24: OSA SYNDROME AND ALLERGIC RESPIRATORY DISEASES Upper Airway Diseases A. Kaditis, MD](https://reader036.vdocuments.us/reader036/viewer/2022062309/56813b7d550346895da49620/html5/thumbnails/24.jpg)
Bhattarjee et al. AT outcomes in Treatment of OSA in Children. AJRCCM 2010; 182:676-683
![Page 25: OSA SYNDROME AND ALLERGIC RESPIRATORY DISEASES Upper Airway Diseases A. Kaditis, MD](https://reader036.vdocuments.us/reader036/viewer/2022062309/56813b7d550346895da49620/html5/thumbnails/25.jpg)
Conclusions
Intermittent upper airway obstruction
during sleep in childhood:
Is associated with disorders affecting upper airway resistance and pharyngeal neuromotor tone
Is related to morbidity from the CNS and the cardiovascular system
Severe upper airway obstruction during sleep and mild obstruction with morbidity or risk factors for persistence should be treated
All disorders leading to upper airway obstruction should be addressed in a stepwise fashion